Eneda Hoxha, PhD, J.D.
VP, IP and Litigation
Nurix
Eneda Hoxha, Ph.D., J.D., is Vice President, Intellectual Property and Litigation at Nurix Therapeutics. Previously, she served as Vice President of Law and Business Development, and Head of Machine Learning at ReCode Therapeutics. Her work sits at the intersection of machine learning, molecular biology, intellectual property, and portfolio strategy. Trained as both a scientist and attorney, she has built and led AI/ML teams within biotechnology organizations and advised on the intellectual property, legal, and strategic considerations associated with the application of machine learning in drug discovery.
Drawing on backgrounds in molecular biology, machine learning, patent litigation, and biotechnology leadership, Dr. Hoxha brings a multidisciplinary perspective on how organizations can leverage AI to accelerate drug discovery while protecting innovation and managing risk.
Sessions
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}